Janus Henderson Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$733K Hold
23,254
﹤0.01% 1761
2025
Q1
$750K Hold
23,254
﹤0.01% 1760
2024
Q4
$841K Hold
23,254
﹤0.01% 1776
2024
Q3
$725K Hold
23,254
﹤0.01% 1836
2024
Q2
$622K Sell
23,254
-271
-1% -$7.25K ﹤0.01% 1874
2024
Q1
$801K Buy
23,525
+2
+0% +$68 ﹤0.01% 1770
2023
Q4
$680K Sell
23,523
-43
-0.2% -$1.24K ﹤0.01% 1849
2023
Q3
$650K Buy
23,566
+3
+0% +$83 ﹤0.01% 1795
2023
Q2
$708K Sell
23,563
-26
-0.1% -$782 ﹤0.01% 1791
2023
Q1
$854K Buy
23,589
+12,894
+121% +$467K ﹤0.01% 1721
2022
Q4
$381K Sell
10,695
-10,695
-50% -$381K ﹤0.01% 1859
2022
Q3
$724K Buy
21,390
+10,707
+100% +$362K ﹤0.01% 1792
2022
Q2
$309K Sell
10,683
-53,543
-83% -$1.55M ﹤0.01% 2060
2022
Q1
$2.08M Sell
64,226
-17,395
-21% -$562K ﹤0.01% 1215
2021
Q4
$2.38M Buy
81,621
+7,494
+10% +$219K ﹤0.01% 1221
2021
Q3
$1.98M Sell
74,127
-12,983
-15% -$346K ﹤0.01% 1258
2021
Q2
$2.68M Sell
87,110
-11,853
-12% -$365K ﹤0.01% 1188
2021
Q1
$2.59M Buy
98,963
+24,620
+33% +$645K ﹤0.01% 1138
2020
Q4
$1.87M Buy
74,343
+7,216
+11% +$182K ﹤0.01% 1134
2020
Q3
$1.4M Buy
67,127
+5,512
+9% +$115K ﹤0.01% 1108
2020
Q2
$1.46M Buy
61,615
+29,473
+92% +$700K ﹤0.01% 1076
2020
Q1
$578K Buy
32,142
+1,695
+6% +$30.5K ﹤0.01% 1164
2019
Q4
$722K Sell
30,447
-635,180
-95% -$15.1M ﹤0.01% 1262
2019
Q3
$18.3M Buy
665,627
+5,107
+0.8% +$140K 0.01% 848
2019
Q2
$21.9M Sell
660,520
-10,275
-2% -$340K 0.01% 774
2019
Q1
$23.5M Buy
670,795
+29,949
+5% +$1.05M 0.01% 747
2018
Q4
$21.3M Sell
640,846
-18,484
-3% -$614K 0.01% 734
2018
Q3
$33.2M Sell
659,330
-6,062
-0.9% -$305K 0.02% 691
2018
Q2
$39.8M Buy
665,392
+118,289
+22% +$7.08M 0.02% 618
2018
Q1
$25.1M Buy
547,103
+123,082
+29% +$5.64M 0.01% 741
2017
Q4
$16.9M Buy
424,021
+157,875
+59% +$6.29M 0.01% 785
2017
Q3
$10.6M Buy
+266,146
New +$10.6M 0.01% 855